A Placebo-controlled, Double-blind, Randomized, Trial of AMZ001 for the Treatment of Knee Osteoarthritis Symptoms
Phase of Trial: Phase II/III
Latest Information Update: 06 Aug 2019
Price : $35 *
At a glance
- Drugs Diclofenac (Primary)
- Indications Musculoskeletal pain
- Focus Therapeutic Use
- Sponsors Amzell
- 16 Jul 2019 Status changed from active, no longer recruiting to completed.
- 02 Jul 2019 Planned End Date changed from 1 Mar 2019 to 12 Jul 2019.
- 02 Jul 2019 Planned primary completion date changed from 1 Mar 2019 to 12 Jul 2019.